![Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study - Kmeid - 2021 - Histopathology - Wiley Online Library Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study - Kmeid - 2021 - Histopathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/170ad8fd-7384-440b-8262-10bbb63fad54/his14420-toc-0001-m.jpg)
Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study - Kmeid - 2021 - Histopathology - Wiley Online Library
![Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13402-019-00436-0/MediaObjects/13402_2019_436_Fig1_HTML.png)
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink
![CDH17 – Improved sensitivity & specifi city for identifi cation of colon and stomach adenocarcinomas - Biocare Medical CDH17 – Improved sensitivity & specifi city for identifi cation of colon and stomach adenocarcinomas - Biocare Medical](https://biocare.net/wp-content/uploads/Cancer-Types.jpg)
CDH17 – Improved sensitivity & specifi city for identifi cation of colon and stomach adenocarcinomas - Biocare Medical
![CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram](https://www.researchgate.net/publication/309378987/figure/fig5/AS:420221606219778@1477200046082/CDX2-marker-as-immunohistochemistry-stain-was-positive-as-brown-color-in-nucleus-of.png)
CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram
![A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10120-020-01064-6/MediaObjects/10120_2020_1064_Fig2_HTML.png)
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink
![Bergen Open Research Archive: Predictive and prognostic markers in localized colon cancer : with emphasis on the biomarkers maspin, mismatch repair deficiency, CDX2, tumor grade, PD-L1, and tumor-infiltrating lymphocytes. Bergen Open Research Archive: Predictive and prognostic markers in localized colon cancer : with emphasis on the biomarkers maspin, mismatch repair deficiency, CDX2, tumor grade, PD-L1, and tumor-infiltrating lymphocytes.](https://bora.uib.no/bora-xmlui/bitstream/handle/11250/2998228/drthesis_2022_hestetun.pdf.jpg?sequence=4&isAllowed=y)
Bergen Open Research Archive: Predictive and prognostic markers in localized colon cancer : with emphasis on the biomarkers maspin, mismatch repair deficiency, CDX2, tumor grade, PD-L1, and tumor-infiltrating lymphocytes.
![Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup](https://www.frontiersin.org/files/MyHome%20Article%20Library/508566/508566_Thumb_400.jpg)
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
![Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - European Journal of Cancer Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2509dc0e-a4ac-46ec-81b1-4b5a325f99b6/gr1.jpg)
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - European Journal of Cancer
![Bergen Open Research Archive: CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup Bergen Open Research Archive: CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup](https://bora.uib.no/bora-xmlui/bitstream/handle/11250/2763452/fonc-10-00008.pdf.jpg?sequence=6&isAllowed=y)
Bergen Open Research Archive: CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
![Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer - European Journal of Cancer Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62cd7bf6-4bb8-4c3a-b0f5-bd22776051f9/gr1_lrg.jpg)
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer - European Journal of Cancer
Distribution of CDX2 expression in patients with colorectal cancer and... | Download Scientific Diagram
![The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report | World Journal of Surgical Oncology | Full Text The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-019-1594-8/MediaObjects/12957_2019_1594_Fig3_HTML.png)
The origin of p40-negative and CDX2-positive primary squamous cell carcinoma of the stomach: case report | World Journal of Surgical Oncology | Full Text
![CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/29/12/5033/F1.large.jpg)
CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research
![Examples of CDX2 expression. a Positive nuclear CDX2 expression in all... | Download Scientific Diagram Examples of CDX2 expression. a Positive nuclear CDX2 expression in all... | Download Scientific Diagram](https://www.researchgate.net/publication/328940735/figure/fig1/AS:825221749682177@1573759605522/Examples-of-CDX2-expression-a-Positive-nuclear-CDX2-expression-in-all-tumour-cells-b.png)
Examples of CDX2 expression. a Positive nuclear CDX2 expression in all... | Download Scientific Diagram
![Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/419c686e-ffb6-49ba-8a14-2bc95b925723/mol212347-fig-0001-m.jpg)
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
![The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas | Modern Pathology The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800205/MediaObjects/41379_2004_Article_BF3800205_Fig1_HTML.jpg)